Regenexx is the only stem cell treatment network to publish this type of analysis of patient stem cell procedure outcome data. The analysis is made possible thanks to the massive numbers that are compiled throughout the years in the Regenexx patient registry, which tracks patient outcomes at regular intervals following all of the stem cell procedures we offer.
Note: This patient outcome data is not part of a controlled trial. Every patient becomes part of a registry to track outcomes and any complications. This data is a compilation of patient input to the Regenexx Patient Registry at regular intervals following their Regenexx Procedure. In addition, none of this data may be reproduced in any way or displayed elsewhere without prior written permission from Regenerative Sciences.
This Regenexx-SD (same-day) bone marrow derived stem cell treatment outcome data analysis is part of the Regenexx data download of patients who were tracked in the Regenexx advanced patient registry.
This Regenexx-SD (same-day) bone marrow derived stem cell treatment outcome data analysis is part of the Regenexx data download of patients who were tracked in the Regenexx advanced patient registry following treatment for Meniscus Tears.
This data utilizes LEFS (Lower Extremity Functional Scale) data from our knee arthritis patients treated with stem cell injections. Functional questionnaires ask the patients questions such as how well they can walk, run, climb stairs, etc. The improvements following the Regenexx-SD procedure are highly statistically significant.
This data looks at patient outcomes for same-day stem cell treatments for hip arthritis.
This outcome information summarizes the patient registry data for shoulders treated with the Regenexx-SD (same-day) procedure using the patient’s own stem cells. It was comprised of a mix of patients with rotator cuff tears, arthritis, labral tears, and instability.
This data was derived from a group of patients with mostly severe thumb arthritis who were injected with their own stem cells. Most of these patients would have been candidates for thumb joint replacement or a surgery where a tendon is coiled up in the joint at the base of the thumb. Both are big surgeries with significant complications.
Most of the foot and ankle patients in this data summary had either moderate or severe main ankle joint arthritis, with many also having either lax ligaments and/or partial tendon tears. A few patients also had sub-talar arthritis. Because this is a smaller data set, all time points were collapsed, such that the last available report was used ( about 17 months post procedure on average).
This outcome information summarizes the patient registry data for Regenexx PL-Disc spine procedures using Platelet Lysate (created from a patient’s own blood).
This data compares two groups of patients who received epidural steroids vs. PL-Disc and looks at their results at 3 month and 6 month intervals using a Functional Rating Index (FRI), which measures things like pain as well as the ability to walk, sit, lift, bend, etc.
We have published more data on stem cell safety in peer reviewed medical research for orthopedic applications than any other group world-wide. Our n=339 stem cell safety paper published in 2011 was named the best of it’s class by independent European researchers last year. This is a report of 1,591 patients and 1,949 procedures treated with the Regenexx-SD procedure. Based on our analysis of this treatment registry data, the Regenexx-SD procedure is about as safe as any typical injection procedure, which is consistent with what we see every day in the clinic.